CECO Environmental Corp. — Q3 2021 Form 10-Q Summary
Business Context and Reporting Period
CECO Environmental provides engineered systems for industrial air-quality control, emissions management, fluid handling, filtration, and related environmental applications. The filing covers the three and nine months ended September 30, 2021, with comparisons to the same periods in 2020. Operations are reported in two segments: Engineered Systems and Industrial Process Solutions.
Financial Highlights
| Metric | Q3 2021 | Q3 2020 | 9M 2021 | 9M 2020 |
|---|---|---|---|---|
| Net sales | $80.0 million | $77.4 million | $230.6 million | $233.1 million |
| Gross profit | $22.7 million | $24.8 million | $72.4 million | $78.9 million |
| Gross margin | 28.4% | 32.0% | 31.4% | 33.8% |
| Operating income (loss) | $(0.6) million | $1.0 million | $4.6 million | $9.7 million |
| GAAP operating margin | (0.8)% | 1.3% | 2.0% | 4.2% |
| Net income (loss attributable to CECO) | $(1.2) million | $(0.2) million | $0.2 million | $6.4 million |
| Diluted EPS | $(0.04) | $(0.01) | $0.01 | $0.18 |
- Non-GAAP operating income was $1.8 million in Q3 and $11.5 million for the first nine months, versus $5.9 million and $19.6 million, respectively, in the comparable 2020 periods. Non-GAAP operating margin was 2.3% in Q3 and 5.0% for nine months.
- Orders booked increased 38.6% year over year to $92.6 million in Q3 and increased 33.5% to $270.2 million for the first nine months.
- Backlog was $219.1 million at September 30, 2021, up from $183.1 million at December 31, 2020. Approximately $3.6 million of previously reported orders were removed for customer cancellations.
- Cash flow from operations was $10.2 million for the first nine months, compared with $9.1 million in 2020. Capital expenditures were $1.7 million.
- Cash, cash equivalents, and restricted cash totaled $34.5 million at September 30, 2021, including $31.9 million of unrestricted cash. Cash declined from $37.8 million at December 31, 2020.
- Total debt under the Credit Facility was $65.9 million, net of debt discount, versus $72.6 million at year-end 2020. The weighted-average stated interest rate was 2.49%.
- Borrowing availability was $37.1 million based on borrowing limitations, with $12.9 million of outstanding letters of credit. The company was in compliance with its debt covenants.
- Working capital was $71.3 million, compared with $74.1 million at December 31, 2020; the current ratio was 1.60 to 1.00.
Material Changes Versus the Prior Comparable Period
- Q3 sales increased 3.4%, but nine-month sales declined 1.1%, reflecting weaker demand in certain markets affected by COVID-19.
- Engineered Systems sales declined 9.9% in Q3 and 12.9% for the first nine months. Segment operating income declined to $4.3 million in Q3 and $16.1 million for nine months, primarily due to lower sales, inflation, supply-chain challenges, and product mix.
- Industrial Process Solutions sales increased 27.0% in Q3 and 20.0% for nine months. Segment operating income increased to $2.7 million in Q3 and $10.9 million for nine months.
- Gross margins contracted due to inflation, supply-chain constraints, logistics costs, labor shortages, and lower-margin project mix.
- Selling and administrative expense increased because 2020 COVID-related furloughs, wage reductions, and travel restrictions did not recur.
- Interest expense declined to $0.7 million in Q3 and $2.2 million for nine months, primarily due to lower debt balances.
- Management realigned and renamed reporting segments in 2021; prior-period segment results were recast.
Guidance, Outlook, Risks, and Unusual Items
- The filing does not provide clear quantitative revenue, earnings, or margin guidance.
- Management reported strong order growth and higher backlog, particularly in electric-vehicle production, engineered wood, aluminum beverage cans, refinery, and power-generation markets. Substantially all backlog is expected to be delivered within 12 to 18 months.
- COVID-19 continues to create uncertainty for demand, international operations, suppliers, labor availability, logistics, and customer timing. Management reported no significant supply-chain disruption to date but noted short-term execution issues and cannot predict the duration or severity of future impacts.
- The company repurchased approximately 521,000 shares for $3.7 million through September 30, 2021, under a $5.0 million authorization expiring December 31, 2021.
- During the nine months, the company recorded $1.5 million of executive transition expense, $0.7 million of restructuring expense, $0.4 million of acquisition and integration expense, and $5.8 million of amortization and earnout expense.
- The company reassessed certain tradenames and transferred $3.2 million from indefinite-lived to finite-lived intangible assets, with 10-year useful lives. No interim goodwill or indefinite-lived intangible impairment trigger was identified as of September 30, 2021.
- There were 223 pending asbestos-related cases at September 30, 2021, versus 200 at year-end 2020. Management believes insurance coverage is adequate and does not currently expect a material adverse impact, but outcomes depend on claim volume, claim characteristics, and insurer coverage.
- Other risks include fixed-price contract exposure, cost overruns, project delays or cancellations, raw-material inflation, warranty and product-liability claims, debt repayment and refinancing, regulatory changes, foreign exchange, cybersecurity, and future COVID-19 developments.
- Disclosure controls and procedures were assessed as effective, and no material changes to internal control over financial reporting were reported.
Investor Verification Checklist
- Verify whether the significant order and backlog increases convert into revenue and improved margins, particularly as supply-chain and labor pressures persist.
- Monitor Engineered Systems recovery, Industrial Process Solutions growth, and the effect of project mix on gross margin.
- Review debt maturities, covenant headroom, borrowing limitations, and the $58.0 million scheduled principal payment in 2024.
- Assess working-capital requirements, including receivables, unbilled contract assets, inventory, and customer cancellations.
- Track remaining share-repurchase authorization and its effect on cash and share count.
- Evaluate asbestos claims, insurance coverage, warranty matters, and other contingencies for changes in expected exposure.
- Reconcile GAAP results with management’s non-GAAP operating measures and the excluded amortization, earnout, restructuring, acquisition, and executive-transition costs.